Learn more

GENESENSE TECHNOLOGIES INC

Overview
  • Total Patents
    76
About

GENESENSE TECHNOLOGIES INC has a total of 76 patent applications. Its first patent ever was published in 1997. It filed its patents most often in Canada, United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are OLIX PHARMACEUTICALS INC, CHATTERTON JON E and EXOSTEM BIOTEC LTD.

Patent filings per year

Chart showing GENESENSE TECHNOLOGIES INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Wright Jim A 66
#2 Young Aiping H 66
#3 Lee Yoon S 22
#4 Dugourd Dominique 8
#5 Lee Yoon 4
#6 Wright J A 3
#7 Young A H 2
#8 Lee Y S 2
#9 Khine Aye-Aye 1
#10 Cao Ming Yu 1

Latest patents

Publication Filing date Title
CA2599754A1 Use of interleukin 17e for the treatment of cancer
WO2006017932A1 Small interfering rna molecules against ribonucleotide reductase and uses thereof
CA2553211A1 Antisense oligonucleotides directed to ribonucleotide reductase r2 and uses thereof in combination therapies for the treatment of cancer
WO2004106518A1 Antisense oligonucleotides directed to ribonucleotide reductase r2 and uses thereof in the treatment of cancer
CA2526393A1 Antisense oligonucleotides directed to ribonucleotide reductase r1 and uses thereof in the treatment of cancer
WO2004070033A1 Antisense oligonucleotides directed to ribonucleotide reductase r2 and uses thereof in the treatment of cancer
CA2535650A1 Antisense oligonucleotides directed against ribonucleotide reductase r2 and uses thereof in the treatment of cancer
AU9732101A Antitumor antisense sequences directed against R1 and R2 components of ribonucleotide reductase
CA2392094A1 Antisense oligonucleotide sequences derived from groel and groes as inhibitors of microorganisms
US6417169B1 Insulin-like growth factor II antisense oligonucleotide sequences and methods of using same to inhibit cell growth
US7087580B2 Neuropilin antisense oligonucleotide sequences and methods of using same to modulate cell growth
US6121000A Antitumor antisense sequences directed against R1 and R2 components of ribonucleotide reductase
US6593305B1 Antitumor antisense sequences directed against R1 and R2 components of ribonucleotide reductase
AU2261299A Oligonucleotide sequences complementary to thioredoxin or thioredoxin reductase genes and methods of using same to modulate cell growth
EP1584681A2 Antisense oligonucleotide sequences as inhibitors of microorganisms
US6610539B1 Antisense oligonucleotide sequences as inhibitors of microorganisms
US6472376B2 Suppression of malignancy utilizing ribonucleotide reductase R1
IL128124D0 Antitumor antisense sequences directed against r1 and r2 components of ribonucleotide reductase
US7223849B1 Oligonucleotides from the untranslated regions of housekeeping genes and methods of using same to modulate cell growth